Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[996]

Thanks Ericteg!

It is remarkable that Elsa again emphasised that predicted revenues are based on those drugs that are selling now and not on future drugs. That makes me think that they will surely reach higher revenue than predicted. That's good.

So we can almost certainly state:
- uplisting in calendar year 2009
- new drug (1 out of the 4 already known) in calender year 2009
- new acquisition and/or new drugs (besides the 4 we already know of) in fiscal year 2010

Yep, I`ve made up my mind, I`ll have to hold on to my shares for a little longer but it will be worth it...



Was there any mention of a future dividend?
How about the share buyback program, was there an update on that?
Money transferring out from china: any progress an this issue?